Science Fair Project Encyclopedia
Thrombin (activated Factor II) is a coagulation protein that has many effects in the coagulation cascade. It is an enzyme of the serine protease type (EC 184.108.40.206), and therefore acts by cleaving proteins at certain locations. Its main action is to turn fibrinogen into fibrin.
Thrombin is produced from prothrombin, which is essentially the inactive state of this protein and produced in the liver. Activated coagulation factors Xa and Va form a complex which is responsible for the conversion of prothrombin to thrombin. Prothrombin is also called factor II and requires vitamin K to be produced. Deficiency of vitamin K or administration of warfarin impair thrombin function.
The active form of factor II, thrombin, has a number of effects on other coagulation proteins. Its most direct effect on clot production is its conversion of fibrinogen into fibrin, but it also feeds back on a number of locations in the coagulation cascade.
Thrombin activates factor XI and factor VIII, increasing the flow through the intrinsic pathway of coagulation. Thrombin also activates factor V of the common pathway, which quickly increases its own production from prothrombin.
Factor XIII, the coagulation protein that cross-links fibrin molecules to stabilize the fibrin clot, is also activated. This increases the speed the fibrin in the clot is covalently linked to itself.
As well as the coagulation pathways, thrombin also promotes platelet aggregration.
Inhibitors and fibrinolysis
Interestingly, thrombin activates protein C, which inhibits coagulation. This happens on the surface of the endothelium, on a protein called thrombomodulin . The formation of activated protein C is important in the digestion of coagulation factors Va and VIIIa, thus thrombin both cleaves fibrinogen to form fibrin and slows down the clotting process (presumably so it doesn't get out of hand).
Role in disease
Activation of prothrombin into thrombin is crucial in physiological and pathological coagulation. Various rare diseases of prothrombin have been described.
An apparently quite common disorder (up to 5% in Western patients) is the substitution of adenine for guanine at position 20210 of the prothrombin gene. Although this falls outside the reading frame for the protein, it leads to high levels of prothrombin and a possibly increased risk of thrombosis (Poort et al 1996).
- Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3' untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703. PMID 8916933.
The contents of this article is licensed from www.wikipedia.org under the GNU Free Documentation License. Click here to see the transparent copy and copyright details